e-learning | Rivaroxaban for preventing atherothrombotic events

26th November 2019 by Louise Hudman

e-learning | Rivaroxaban for preventing atherothrombotic events

This is a new guideline from NICE advising that rivaroxaban plus aspirin can be used in the prevention of atherothrombotic events, under certain circumstances. It was published in Oct 2019. This is quite a big change in practice.

Rivaroxaban can be used together with aspirin as an option for the prevention of atherothrombotic events in adults with

Coronary artery disease OR symptomatic peripheral artery disease…

…and…

…those who are at high risk of ischaemic events:

  • Aged 65 or over OR
  • Have atherosclerosis in at least 2 areas (eg coronary, cerebrovascular or peripheral arteries) OR
  • Have 2 or more of the following risk factors:
    • current smoking
    • diabetes
    • CKD with eGFR < 60
    • heart failure
    • previous non-lacunar ischaemic stroke.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

Related content

"I really like LocumDeck. Before, I was doing everything myself. It was a nightmare! Keeping a record of who has paid, chasing them – with LocumDeck, all that goes away. All you have to do is just book your sessions and work."

Dr Vin Ohja

Dr Vin Ohja

See the full list of features within our NASGP membership plans

Membership